BLB(SZ:002286)2024-07-01 11:07Financial Performance - The estimated net profit attributable to shareholders for the first half of 2024 is projected to be between 58 million and 75 million CNY, representing a year-on-year increase of 77.05% to 128.94% compared to 32.76 million CNY in the same period last year [2]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between 57 million and 70 million CNY, reflecting a year-on-year growth of 212.55% to 283.83% from 18.24 million CNY in the previous year [2]. - The basic earnings per share is projected to be between 0.1595 CNY and 0.2038 CNY, compared to 0.09 CNY in the same period last year [2]. - The performance forecast is based on preliminary estimates and has not been audited by an accounting firm; final financial data will be disclosed in the 2024 semi-annual report [5]. Cost Management - The company has optimized production processes for prebiotics, dietary fibers, and sugar substitute products, leading to a decrease in production costs compared to the same period last year [4]. - The prices of key raw materials such as corn and corn starch, as well as energy procurement costs, have decreased compared to the same period in 2023 [4]. Marketing Strategy - The company has adjusted its marketing strategy to enhance incentives for differentiated and high-margin products, resulting in an improved product structure and gross margin [4].